Wen-Ping Xu

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• Deletion of Sox9 in the liver leads to hepatic cystogenesis in mice by transcriptionally downregulating Sec63
  The Journal of Pathology 2021 7 citations DOI: 10.1002/PATH.5636
  +Save
• The prevalence and associated factors of simple hepatic cysts in Shanghai: a population-based cross-sectional study
  Chinese Medical Journal 2021 3 citations DOI: 10.1097/CM9.0000000000001361
  +Save
• miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
  Gut 2020 136 citations DOI: 10.1136/GUTJNL-2019-318830
  +Save
• Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α
  Theranostics 2019 48 citations DOI: 10.7150/THNO.32344
  +Save
• Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein evaluates liver function and predicts prognosis in liver cirrhosis
  Journal of Digestive Diseases 2018 12 citations DOI: 10.1111/1751-2980.12596
  +Save
• Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma
  Oncotarget 2016 28 citations DOI: 10.18632/ONCOTARGET.8478
  +Save
• Differentiation therapy for solid tumors
  Journal of Digestive Diseases 2014 46 citations DOI: 10.1111/1751-2980.12122
  +Save
• Hepatocyte Nuclear Factor 4α-Nuclear Factor-κB Feedback Circuit Modulates Liver Cancer Progression
  Hepatology 2014 105 citations DOI: 10.1002/HEP.27177
  +Save
• C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades
  Digestive and Liver Disease 2013 11 citations DOI: 10.1016/J.DLD.2013.03.013
  +Save
• Hepatocyte Nuclear Factor-4a Reverses Malignancy of Hepatocellular Carcinoma Through Regulating miR-134 in the DLK1-DIO3 Region
  Hepatology 2013 82 citations DOI: 10.1002/HEP.26573
  +Save